| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| GLSI | $13.35 | -3.331% | 34 | 30 | $175 | $10.80 | 23.6% |
Greenwich LifeSciences, Inc.
Building 14
3992 Bluebonnet Drive
Stafford, TX 77477
United States
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01.